Position in ZLAB
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$2,765
-$39 QoQ
Shares Held
147
-7.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ZLAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026DEUTSCHE BANK AG\ holds $2,973,536,998 across 248 Biotechnology names. ZLAB ranks #245 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,537,736 | $686,660,626 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
625,388 | $483,199,777 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
761,464 | $251,945,590 | |
| 4 | INCY |
Incyte Corp
|
1,264,195 | $118,986,027 | |
| 5 | RPRX |
Royalty Pharma plc
|
2,453,303 | $117,684,942 | |
| 6 | ARGX |
Argenx SE
|
139,381 | $101,782,972 | |
| 7 | INSM |
INSMED Inc
|
562,474 | $91,975,745 | |
| 8 | LGND |
Ligand Pharmaceuticals Inc
|
306,111 | $61,115,059 |
All Filings in ZLAB
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $2,765 | 147 | Shares | Defined | 2026-05-06 | |
| 2025-12-31 | $2,804 | 159 | Shares | Defined | 2026-02-11 | |
| 2025-09-30 | $4,575 | 135 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $4,720 | 135 | Shares | Defined | 2025-08-12 | |
| 2025-03-31 | $5,746 | 159 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $8,695 | 332 | Shares | Defined | 2025-06-30 | |
| 2024-09-30 | $23,536 | 975 | Shares | Defined | 2025-06-26 | |
| 2024-06-30 | $37,709 | 2,176 | Shares | Defined | 2025-06-12 | |
| 2024-03-31 | $183,844 | 11,476 | Shares | Defined | 2025-06-02 | |
| 2023-12-31 | $326,209 | 11,936 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $420,927 | 17,315 | Shares | Defined | 2023-11-24 | |
| 2023-06-30 | $552,907 | 19,939 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $6,552,317 | 197,003 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $9,496,981 | 309,348 | Shares | Defined | 2023-02-13 | |
| 2022-09-30 | $13,413,376 | 392,204 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $13,442,729 | 387,622 | Shares | Defined | 2022-08-11 | |
| 2022-03-31 | $16,011,489 | 364,063 | Shares | Defined | 2022-05-13 | |
| 2021-12-31 | $25,472,159 | 405,285 | Shares | Defined | 2022-02-16 | |
| 2021-09-30 | $42,126,594 | 399,721 | Shares | Defined | 2021-11-04 | |
| 2021-06-30 | $70,834,758 | 400,219 | Shares | Defined | 2021-08-11 | |
| 2021-03-31 | $50,687,385 | 379,880 | Shares | Defined | 2021-05-13 | |
| 2020-12-31 | $21,764,565 | 160,814 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $13,776,276 | 165,640 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $10,949,322 | 133,317 | Shares | Defined | 2020-08-13 | |
| 2020-03-31 | $5,552,528 | 107,858 | Shares | Defined | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||